Platinum Investment Management Ltd. grew its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,770,451 shares of the company’s stock after buying an additional 60,112 shares during the period. Platinum Investment Management Ltd.’s […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 1,231,280 shares traded hands during trading, a decline of 61% from the previous session’s volume of 3,169,160 shares.The stock last traded at $8.81 and had previously closed at $9.38. Analysts Set New Price Targets A number of analysts […]
Recursion Pharmaceuticals, Inc (NASDAQ:RXRX) CFO Michael Secora Sells 25,000 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 17,770 shares of the company’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $11.16, for a total transaction of $198,313.20. Following the completion of the sale, the director now directly owns 7,469,615 shares of […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 17,770 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $11.16, for a total value of $198,313.20. Following the sale, the director now directly owns 7,469,615 shares in the company, valued […]